Physician profile
Vyshak Chandra
NPI 1629563440
$73,219.57
in general payments reported to CMS, 2019-2025
15 companies · $15K in 2025
The $15K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55K · 2022: $176 · 2023: $1,815 · 2024: $673 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,610 · Consulting Fee: $6,160 · Food and Beverage: $4,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,610.15 |
| Consulting Fee | $6,160.00 |
| Food and Beverage | $4,037.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,871.33 | 2021-2025 | General - Pain Management, General - Dbs, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $25,515.68 | 2021-2025 | Mazor X System, Intellis Adaptivestim, Percept PC Brainsense |
| Depuy Synthes Products, INC. | $7,005.56 | 2025 | Velys |
| Medical Device Business Services, INC. | $2,568.81 | 2021-2025 | Velys |
| Si-Bone, INC. | $2,519.82 | 2025 | |
| Clearpoint Neuro, INC. | $1,647.32 | 2023 | Clearpoint |
| Alphatec Spine, INC | $1,017.18 | 2025 | Other - Miscellaneous |
| Depuy Synthes Sales INC. | $561.74 | 2024-2025 | Synthecel, Matrixneuro, Teligen |
| Saluda Medical Americas, INC. | $509.98 | 2024-2025 | Evoke |
| Team 1, LLC | $446.36 | 2025 | |
| Carlsmed, INC. | $182.18 | 2025 | Aprevo |
| Stryker Corporation | $167.60 | 2023 | N/A |
| Coastal Medical Technologies LLC | $81.42 | 2025 | |
| Providence Medical Technology, INC. | $67.29 | 2025 | |
| Monteris Medical Corporation | $57.30 | 2025 | Neuroblate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vyshak Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.